Q4 CC is Friday morning and the current VMAT2 P2b trial for TD is an open trial so Management knows all their is to know and I bet the results are stella. No adverse events reported ect ect ect.
VMAT2 could be a significant PPS driver for investors and given big pharmas need for new revenue/drugs to fill their pipelines. The street IMO is looking at NBIX ...... buy buy buy
NBIX holding on to yesterdays gains today Can it go green this afternoon?????
Now that would be a huge PPS positive
looking good, but not sure what happened to cause the jump.
Sentiment: Strong Buy
What a difference a day makes? Looks like defensive selling ahead of tomorrow's call. Understandable.